Allison Dorval
Vermogen: 540 546 $ op 31-05-2026
Vermogen: 540 546 $ op 31-05-2026
Allison Dorval is currently an Independent Director at Puma Biotechnology, Inc. since 2021.
Former positions include Independent Director at Jade Biosciences, Inc. from 2021 to 2025; Vice President & Controller at Catalent JNP, Inc. from 2016 to 2017; Chief Financial Officer at Arsenal Medical, Inc. from 2015 to 2016; Chief Financial Officer at Lyra Therapeutics, Inc. from 2015 to 2016; Chief Financial Officer at Insulet Corp.
from 2014 to 2015; Chief Financial & Accounting Officer at Verve Therapeutics, Inc. from 2021 to 2025; Chief Financial Officer at Voyager Therapeutics, Inc. from 2018 to 2021; Finance Director at Digitas, Inc.; Assistant Controller at iBASIS, Inc.; and Principal at PricewaterhouseCoopers LLP.
Education includes undergraduate studies at the University of Vermont.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-04-2026 | 75.390 ( 0,15% ) | 540 546 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Directeur/Bestuurslid | 15-07-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VERE THER | Financieel Directeur/CFO | 25-07-2025 |
| JADE BIOSCIENCES, INC. | Directeur/Bestuurslid | 28-04-2025 |
| VOYAGER THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-11-2021 |
| JUNIPER PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01-06-2017 |
| LYRA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-08-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Catalent JNP, Inc.
Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
iBASIS, Inc.
iBASIS, Inc. Specialty TelecommunicationsCommunications Provides voice, mobile, messaging, IoT and cloud solutions | Communications |
Digitas, Inc.
Digitas, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital and interactive marketing services | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Arsenal Medical, Inc.
Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Health Technology |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau